β2-AGONISTS



Summary

The β2-agonists are the most offective bronchodilators  available .  β2-Adrenergic receptor stimulation activates adenyl cuclase,which produces an increase in intraccllular cyclic AMP. This in turn decreases unbound intracellular calcium , producings smooth muscle relaxation.Mast-cell membrane stabilization, and skeletal muscle stimulation.β2 Adrenergic stimulation also activatcs Na’    K’ ATPasc, produces gluconeogenesis , and enhances insulin secretion, producing a mild to moderate decrease in serum potassium concentration.

The Table compares the various β-adrenergic agonists in terms of selectivity.Potency, oral activity , and duration of action.The β2-agonists are functional or physiologic antagonists in that they relax airway smooth muscle regardless of the mechanism for constriction.When administered in equipotent doses , all the short-acting drugs will produce the same intensity of response , the only differences will be in duration of action and cardiac toxicity . All of the β -agonists are more bronchoselective when administered by the aerosol route , Differences in myocardial effect are discernible between selective and nonslective agents even when administered as aerosols . particularly at the higher doses used for acute severe asthma.

 Table. Relative Selectivity , Potency  and Duration of Action of the B-Adrenegic Agonists
                          
         
Agent                     Selectivity                    Duration of Action      Oral                          
                                   B1          B2         B3  Bronchodilation   Protectionb  Activity
                                                            Potency a        (h)                (h)

Isoproterenol
Metlaproterenol
Losetharine
Albuterol
Bitolterol
Pirbuterol
Terbutaline
Formoterol
Salmeterol

+ + + +
  |   |   |
   +  +

 

 

     +

 + + + +
   |   |   |
   + + + 

 

 
 + + + +
 + + + +

1
15
6
2
5
5
4
0.24
0.25

0.5-2.0
3-4
0.5-2.0
4-8
4-8
4-8
4-8
>12
>12

0.5-1.0
1-2
0.5-1.0
2-4
2-4
2-4
2-4
>12
>12

No
Yes
No
Yes
No
Yes
Yes
Yes
Yes

  a) Relative molar potency : β 1 most patent.

b)     b) Protection refers to the duration of time that bronchocoustriction may be prevented

 

Previous Page

Next Page